MarketPeel
Insider Trading Intelligence
Pricing
…
BB

Brian Baranick

EXAS
EVP, GM, PRECISION ONCOLOGY · EXACT SCIENCES CORP · CIK 0001941313
FILING MIX · LIFETIME38%/62%
BUYS
30
SELLS
50
TOTAL VALUE
$10.45M
COMPANIES
1
ACTIVE SINCE
Aug 2022
HOLDINGS NOW
0
AVG SELL PX
$89.65
TRADE KIND
SHOWING 80 / 80
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
14 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Brian Baranick, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d14+57.14%-1.86%+0.85%-2.71%-2.94%—
14d14+57.14%-4.31%+0.62%-4.93%-1.68%—
30d14+50.00%-0.30%+1.83%-2.13%-1.47%—
60d14+64.29%-8.26%+1.92%-10.18%-8.76%—
90d14+78.57%-8.21%+4.07%-12.28%-20.55%—
180d14+53.85%-2.26%+8.58%-11.01%-11.91%—
1y14(1 pending)+92.31%-12.73%+19.43%-32.16%-37.58%—
2y14(3 pending)+30.00%+29.91%+41.15%-10.77%+2.68%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
EXAS · 0 shares · as of Mar 23, 2026
034,29968,598102,896137,1952023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 30 buys / 50 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
137,195——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
795——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
33,321——137,195Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
28,063——0Mar 23, 2026Mar 23, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
28,063——28,063Feb 25, 2026Feb 27, 2026 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
14,938$101.59$1.52M103,874Dec 24, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
29,416——118,812Dec 24, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
4,799$101.82$488.6K28,965Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
14,845——43,810Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
16,051——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,009$101.82$204.6K24,314Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
14,845——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
42,523——100,859Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
28,779——65,050Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
9,450——33,764Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
21,594$101.82$2.20M79,265Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
28,779——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
16,051——66,487Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
7,539$101.82$767.6K36,271Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
9,450——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
8,151$101.82$829.9K58,336Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
20,584——99,849Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
14,614$101.82$1.49M50,436Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
10,453$101.82$1.06M89,396Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
3,955——0Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
3,955——26,323Dec 23, 2025Dec 30, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
2,858$70.08$200.3K22,368Nov 4, 2025Nov 6, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,717$46.83$127.2K25,226Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
5,350——16,051Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
5,350——27,943Aug 5, 2025Aug 7, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
4,948——25,106Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
4,725——9,450Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
4,725——22,558Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
4,948——14,845Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,400$47.82$114.8K20,158Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,513$47.82$120.2K22,593Feb 28, 2025Mar 4, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
3,954——19,841Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
3,954——3,955Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,008$51.28$103.0K17,833Feb 25, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
28,779——28,779Feb 24, 2025Feb 26, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
4,805——18,324Feb 20, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,437$50.48$123.0K15,887Feb 20, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
968$49.63$48.0K13,519Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
1,729——0Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
1,729——14,487Feb 19, 2025Feb 21, 2025 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
929$70.00$65.0K12,758Oct 8, 2024Oct 9, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
929$70.00$65.0K13,687Sep 18, 2024Sep 19, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
21,401——21,401Aug 5, 2024Aug 6, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
1,375$55.77$76.7K14,616Aug 5, 2024Aug 6, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
EVP, GM, Precision Oncology
2,712——0Aug 5, 2024Aug 6, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
EVP, GM, Precision Oncology
2,712——15,991Aug 5, 2024Aug 6, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
110$60.15$6.6K13,279May 1, 2024May 2, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
218——13,389Apr 30, 2024May 2, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
924$79.43$73.4K13,171Apr 2, 2024Apr 3, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
2,323$59.32$137.8K14,095Mar 1, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
4,724——14,175Feb 29, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
4,724——16,418Feb 29, 2024Mar 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
2,027$56.89$115.3K11,694Feb 27, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
3,954——13,721Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
19,793——19,793Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
3,954——7,909Feb 26, 2024Feb 28, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,093$59.78$65.3K9,767Feb 22, 2024Feb 23, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
895$61.50$55.0K8,826Feb 21, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
2,034——10,860Feb 21, 2024Feb 23, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
1,729——9,721Feb 20, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
1,729——0Feb 20, 2024Feb 22, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
879$73.50$64.6K7,992Jan 2, 2024Jan 4, 2024 ↗View →
EXAS
EXACT SCIENCES CORP
SALE10b5-1
10b5-1 plan
1,350$85.04$114.8K8,871Aug 7, 2023Aug 8, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
2,712——2,712Aug 4, 2023Aug 8, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
2,712——10,221Aug 4, 2023Aug 8, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
1,932$61.12$118.1K7,509Feb 28, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
3,954——11,863Feb 27, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
3,954——9,441Feb 27, 2023Mar 1, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASEGRANT
Stock grant
18,899——18,899Feb 24, 2023Feb 28, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
838$62.72$52.6K5,487Feb 22, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
1,729——6,325Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
1,729——3,458Feb 21, 2023Feb 23, 2023 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
984$47.12$46.4K4,596Aug 5, 2022Aug 8, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
SALE
Gen. Mgr., Precision Oncology
2,712——5,424Aug 4, 2022Aug 8, 2022 ↗View →
EXAS
EXACT SCIENCES CORP
PURCHASE
Gen. Mgr., Precision Oncology
2,712——5,580Aug 4, 2022Aug 8, 2022 ↗View →
Other insiders · EXAS
Loading peer insiders…
About this filer
CIK 0001941313
ROLE
EVP, GM, Precision Oncology
PRIMARY
EXAS
COMPANIES
1
ACTIVE SINCE
Aug 2022
MARKETPEEL · /INSIDER/0001941313DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback